Chemotherapy sensitive genes and proteins in esophageal carcinoma
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1673-422X.2011.04.014
   		
        
        	
        		- VernacularTitle:食管癌化疗敏感相关基因及蛋白
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Feng LIU
			        		
			        		;
		        		
		        		
		        		
			        		Chao JIANG
			        		
			        		;
		        		
		        		
		        		
			        		Xigui YANG
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Esophageal neoplasms;
			        		
			        		
			        		
				        		Receptor,epidermal growth factor;
			        		
			        		
			        		
				        		Genes,p53;
			        		
			        		
			        		
				        		Multidrug resistance-associated proteins;
			        		
			        		
			        		
				        		P-glycoprotein
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Journal of International Oncology
	            		
	            		 2011;38(4):285-289
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	With the deep study of the molecular biology mechanism during esophageal carcinoma development, there are major progressions in the study of chemotherapy related genes and proteins in esophageal carcinoma, including EGFR, p53, ERCC1, MRP and P-gp, and the measurements of these genes and protein benefit the prediction of chemotherapy sensitivity and making the individualized treatment protocols.